|
⚲
|
| Keyboard |
| Third Rock Ventures LLC
✚
|
|
|---|---|
| CRD # | 161185 |
| SEC # | 802-75143 |
| CIK # | 0001408591, 0001600135 |
| AUM | |
| Employees | |
| Phone | 617-585-2000 |
| Address | 201 Brookline Ave Boston, MA 02215 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Third Rock Ventures VI LP | [2023-03-29] | 1,105.3 M | 786.6 M |
| Offered $1,105,340,000 · Filed 2022-06-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $500,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Third Rock Ventures V LP | [2020-03-27] | 750.0 M | 736.1 M |
| Offered $750,000,000 · Filed 2019-06-07 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $200,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Third Rock Ventures IV LP | [2017-03-23] | 600.0 M | 326.5 M |
| Offered $600,000,000 · Filed 2016-11-02 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Third Rock Ventures III LP | [2013-03-27] | 500.0 M | 41.8 M |
| Offered $500,000,000 · Filed 2013-03-25 (D) · Exemption 506, 3(c), 3(c)(7) · Minimum $150,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Third Rock Ventures II LP | [2012-03-28] | 7.9 M | |
| Offered $400,000,000 · Filed 2010-04-09 (D) · Exemption 506, 3(c), 3(c)(7) · Remaining $400,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Third Rock Ventures LP | [2012-03-28] | 40.7 M | |
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| David Kaufman | Executive Officer | 48 | 3 | |
| Alexis Borisy | Executive Officer | 23 | 3 | |
| Robert Tepper | Executive Officer | 35 | 2 | |
| Mark Levin | Executive Officer | 26 | 2 | |
| Neil Exter | Executive Officer | 25 | 2 | |
| Kevin Starr | Executive Officer | 21 | 2 | |
| Abbie Celniker | Executive Officer | 14 | 2 | |
| Cary Pfeffer | Executive Officer | 12 | 2 | |
| Jeffrey Tong | Executive Officer | 9 | 2 | |
| Steven Kafka | Executive Officer | 7 | 2 | |
| Reid Huber | Executive Officer | 7 | 2 | |
| Kevin Gillis | Executive Officer | 6 | 2 | |
| Christoph Lengauer | Executive Officer | 5 | 2 | |
| Craig Muir | Executive Officer | 4 | 2 | |
| Third Rock Ventures GP IV LP | Promoter | 1 | 1 | |
| Trv GP IV LLC | Promoter | 1 | 1 | |
| Third Rock Ventures GP III LP | Director | 1 | 1 | |
| Sarah Larson | Executive Officer | 1 | 1 | |
| Trv GP V LLC | Promoter | 1 | 1 | |
| Trv GP II LLC | Executive Officer | 1 | 1 | |
| Third Rock Ventures GP VI LP | Executive Officer | 1 | 1 | |
| Third Rock Ventures GP II LP | Executive Officer | 1 | 1 | |
| Third Rock Ventures GP V LP | Promoter | 1 | 1 | |
| Trv GP VI LLC | Executive Officer | 1 | 1 | |
| Trv GP III LLC | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001408591] | |
| 4 | [0001408591] | |
| SC 13D | [0001408591] | |
| SC 13G | [0001408591] | |
| 13F-HR | [0001600135] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals Inc RYTM
Common Stock
|
2018-08-30 | Other | 1,000,000 | ||
|
Constellation Pharmaceuticals Inc CNST
Common Stock
|
2018-08-22 | Option exercise | 51,032 | $1.55 | 79,100 |
|
Constellation Pharmaceuticals Inc CNST
Warrant (right to buy) · derivative
|
2018-08-22 | Option exercise | 51,032 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Common Stock
|
2018-07-23 | Buy | 266,667 | $15.00 | 4,000,005 |
|
Constellation Pharmaceuticals Inc CNST
Common Stock
|
2018-07-23 | Conversion | 2,705,334 | ||
|
Constellation Pharmaceuticals Inc CNST
Series E-1 Preferred Stock · derivative
|
2018-07-23 | Conversion | 3,107,930 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series E Preferred Stock · derivative
|
2018-07-23 | Conversion | 2,285,640 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series D Preferred Stock · derivative
|
2018-07-23 | Conversion | 1,086,411 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series B Preferred Stock · derivative
|
2018-07-23 | Conversion | 10,650,000 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series A Preferred Stock · derivative
|
2018-07-23 | Conversion | 11,000,000 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series F Preferred Stock · derivative
|
2018-07-23 | Conversion | 1,000,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2017-10-18 | Other | 1,000,000 | ||
|
Rhythm Pharmaceuticals Inc RYTM
Common Stock
|
2017-10-10 | Conversion | 3,963,810 | ||
|
Rhythm Pharmaceuticals Inc RYTM
Series A-1 Junior Preferred Stock · derivative
|
2017-10-10 | Conversion | 26,868,642 | $0.00 | |
|
Rhythm Pharmaceuticals Inc RYTM
Series A Convertible Preferred Stock · derivative
|
2017-10-10 | Conversion | 9,479,502 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2017-07-13 | Other | 850,000 | ||
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2017-03-27 | Sell | 650,000 | $18.00 | 11,700,000 |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2017-03-23 | Sell | 1,000,000 | $17.00 | 17,000,000 |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2017-03-15 | Other | 850,000 | ||
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2016-11-07 | Other | 1,000,000 | ||
| showing 20 of 92 most recent transactions | |||||